Heart diseases of any entity and etiology
Conditions
Interventions
Group 1: Male patients aged 18–59 years with a congenital heart disease (Group A) will participate in a single individual semi-structured interview. The focus is on gender- and generativity-related as
Sponsors
Carl von Ossietzky Universität Oldenburg, Fakultät VI - Medizin und Gesundheitswissenschaften, Department für Versorgungsforschung, Abteilung Ethik in der Medizin
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion criteria for the group of patients with congenital heart disease: Participants aged 18 to 59 years with a moderate to severe congenital heart defect, i.e., a congenital anatomical anomaly of the heart requiring medical treatment, who have sufficient knowledge of the German language and provide informed consent to participate in the study, including audio- and videorecording of the interviews. Inclusion criteria for the group of patients with heart disease first diagnosed in adulthood: Participants aged 30 to 59 years with one of the following heart conditions: symptomatic heart failure (NYHA II–IV) of any type or etiology, coronary artery disease with history of myocardial infarction and/or coronary intervention or surgery, cardiac arrhythmia with pacemaker/ICD implantation or other invasive/operative procedure, or status post defibrillation or cardioversion, who have sufficient knowledge of the German language and provide informed consent to participate in the study, including audio- and videorecording of the interviews. Inclusion criteria for the group of older patients with heart disease: Participants aged over 70 years with a leading advanced heart condition as defined in one of the other two groups, who have sufficient knowledge of the German language and provide informed consent to participate in the study, including audio- and videorecording of the interviews.
Exclusion criteria
Exclusion criteria: General exclusion criteria (applicable to all three groups) include insufficient knowledge of the German language, lack of cognitive ability to participate in 90-minute interviews, cognitive impairment such as intellectual disability or dementia, the presence of a severe psychiatric disorder (e.g., severe dementia, schizophrenia or other psychotic disorders, severe depressive episode, bipolar disorder with a current manic or severe depressive episode, or pronounced substance use disorder), and/or a serious medical condition (e.g., advanced cancer or neurodegenerative disease) that could distort the participants’ experiences or represent a primary focus on another illness. No exclusion will occur for psychiatric or psychosomatic conditions such as mild to moderate depressive episodes, anxiety disorders, somatoform cardiac complaints, post-traumatic stress disorder, or adjustment disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Using semi-structured interviews, the following primary endpoints will be assessed: (1) Gender- and sex-specific conceptions of the good life and reported changes in the experience of time among middle-aged (biologically) male versus female heart patients, including (a) adults with congenital heart diseasee, and (b) individuals with heart disease first diagnosed in adulthood. (2) The influence of different forms of generativity – that is, of “passing on” in order to enable the flourishing of subsequent generations – (midlife vs. late-life generativity; reproductive vs. institutional forms) on temporal conceptions of the good life in these patient groups. (3) Age-specific similarities and differences between female and male heart patients regarding conceptions of the good life and reported changes in temporal experience, with particular attention to different forms of generativity, comparing older heart patients (aged 70 and above) with middle-aged heart patients. | — |
Secondary
| Measure | Time frame |
|---|---|
| The project further aims to develop a computer-adaptive self-assessment instrument (CAT) for evaluating quality of life, integrating the qualitative findings from the first project phase (DRKS00028096) and the additional dimensions described above. | — |
Countries
Germany
Contacts
Public ContactDaniel Broschmann
Universitätsmedizin Göttingen - Klinik für Psychosomatische Medizin und Psychotherapie
Outcome results
None listed